Trials / Completed
CompletedNCT04701125
Medical Cooling of Ice Hockey Players
Selective Head-neck Cooling Following Concussion Shortens Return-to-play in Ice Hockey Players
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 81 (actual)
- Sponsor
- Region Skane · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The incidence of Sports-related concussions (SRCs) has risen in recent years, not least in ice hockey, and available treatment options are limited. Here, we addressed the hypotheses that immediate controlled head- and neck cooling could hasten return-to-play in a Swedish cohort of concussed professional ice hockey players. Over three seasons, 15 teams used either immediate head- and neck cooling or standard management for SRC. All players (81) followed the same return-to-play management protocol.
Detailed description
Sports-related concussions (SRCs) are a growing health concern, since they may lead to persistent symptoms and, particularly if repeated, to e.g. depression, accelerated dementia onset, and development of chronic traumatic encephalopathy. Here, we addressed the hypotheses that immediate controlled head- and neck cooling could hasten return-to-play in a Swedish cohort of concussed professional ice hockey players. Over three seasons, 15 teams used either immediate head- and neck cooling or standard management for SRC. All players followed the same return-to-play management protocol. Using a baseline questionnaire, no difference in the number of previous SRCs between groups was observed. In total, 92 SRCs were recorded. Eleven players did not complete the study protocol, and thus 81 players were included. Of these, 29 were treated by immediate selective head- and neck cooling for ≥ 30 min, and 52 controls received standard acute SRC management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | selective head-neck cooling using PolarCap system | Players receiving selective head-neck cooling after SRC |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2020-06-01
- Completion
- 2020-07-01
- First posted
- 2021-01-08
- Last updated
- 2021-01-08
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT04701125. Inclusion in this directory is not an endorsement.